PATENT CLAIM ANALYSIS

Application Number: 15978271
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["530", "327000"]

Abstract:
The present invention provides inhibitors and/or antagonists of plasma kallikrein. Also provided are methods of utilizing the inhibitors as therapeutics.

Claim (Index 7):
The method of  claim 1 , wherein delivery of said one or more peptides is selected from one or more of subcutaneous delivery, oral delivery, topical delivery, intravitreal delivery, nasal delivery, intravenous delivery, intraarterial delivery, intramuscular delivery, intraperitoneal delivery, and transmucosal delivery.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.15789
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15459035', '14401697', '14962457', '15614047', '11923307']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7343059247600502
- 35 USC 102 Novelty (BERT): 0.5680688136708621
- Combined Prediction Score: 0.7176822136511314
- Mean Citation Score: 381.31615
- Max Citation Score: 511.45996
- Similarity Product: 367.0877719237018

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test